PATENT CLAIM ANALYSIS

Application Number: 16192404
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-10
Patent Classification: ["514", "017600"]

Abstract:
The present invention provides methods for treating or alleviating one or more symptoms of depression and/or anxiety in a subject comprising administering an effective amount of an NCAM peptide mimetic to the subject. The symptoms of depression and/or anxiety are typically observed in or associated with a neurological condition. The present invention also provides methods for treating a neurological condition such as a psychiatric disorder in a subject comprising administering an effective amount of an NCAM peptide mimetic to the subject.

Claim (Index 44):
The method of  claim 43 , wherein the multimer is a dimer, tetramer, or dendrimer, and wherein Z is the same peptide or different peptides.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13431893', '12708384', '12523035', '12524903', '13112290']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7587635251793302
- 35 USC 102 Novelty (BERT): 0.5123866106805587
- Combined Prediction Score: 0.7341258337294531
- Mean Citation Score: 205.688376
- Max Citation Score: 253.34935
- Similarity Product: 159.69900279062392

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test